Akebia Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akebia Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
  • Akebia Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$8.73M, a 3.01% increase year-over-year.
  • Akebia Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$35.3M, a 60.7% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$46.3M, a 42.7% increase from 2022.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$80.8M, a 69.5% increase from 2021.
  • Akebia Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$265M, a 30% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$35.3M -$8.73M +$271K +3.01% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$35.6M -$14.9M +$10.7M +41.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$46.3M $1.37M +$6.24M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$52.5M -$13M +$37.4M +74.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$89.9M -$9M -$43.1M -126% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$46.8M -$25.6M +$34M +57% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$80.8M -$4.87M +$60.5M +92.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$141M -$50.4M +$4.48M +8.16% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$146M $34.1M +$113M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-28
Q1 2022 -$259M -$59.6M +$5.36M +8.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-28
Q4 2021 -$265M -$65.3M +$20.1M +23.5% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 -$285M -$54.9M +$3.21M +5.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$288M -$79.3M +$94.5M +54.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$382M -$64.9M -$5.81M -9.83% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$376M -$85.4M +$9.49M +10% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$386M -$58.1M -$2.19M -3.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$384M -$174M -$114M -192% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$269M -$59.1M +$16.8M +22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$286M -$94.9M -$4.73M -5.25% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$282M -$55.9M -$28.1M -101% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$253M -$59.5M -$23.9M -66.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$230M -$76M -$51.5M -210% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$178M -$90.2M -$105M -717% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$73.4M -$27.8M -$3.67M -15.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$69.7M -$35.7M -$13.5M -61.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$56.2M -$24.5M +$20.5M +45.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$76.7M $14.6M +$52.7M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$129M -$24.2M +$12M +33.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-26
Q2 2017 -$141M -$22.1M +$14.1M +38.8% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-26
Q1 2017 -$155M -$45M -$18.9M -72.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-26
Q4 2016 -$136M -$38M -$18M -89.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$118M -$36.2M -$16.5M -83.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$102M -$36.2M -$25.3M -232% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$76.7M -$26M -$15.2M -139% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$61.5M -$20.1M -$9.44M -89% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$52.1M -$19.7M -$10.1M -105% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$42M -$10.9M -$3.05M -38.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$38.9M -$10.9M -$987K -9.96% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$37.9M -$10.6M -$4.41M -71.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$33.5M -$9.58M -$5.55M -138% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$28M -$7.84M -$4.72M -151% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$23.3M -$9.91M -$7.33M -285% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$15.9M -$6.2M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$4.03M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-04
Q2 2013 -$3.12M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-04
Q1 2013 -$2.58M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.